81
Study of TRC102 in Combination With Pemetrexed in Cancer Patients
Condition(s): Neoplasm Last Updated: September 8, 2010Completed
466 Clinical Trials for: Pemetrexed, Page 5 of 24
Hide Studies Not Seeking New Volunteers
82
Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer
Condition(s): Lung Cancer Last Updated: September 26, 2012Active, not recruiting
83
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Condition(s): Ovarian Carcinoma; Primary Peritoneal Carcinoma Last Updated: December 20, 2012Completed
84
Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)
Condition(s): Non Small Cell Lung Cancer Last Updated: December 14, 2009Completed
85
AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer
Condition(s): Recurrent Non-small Cell Lung Cancer Last Updated: April 9, 2013Active, not recruiting
86
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
Condition(s): Esophageal Neoplasms Last Updated: March 1, 2013Terminated
87
Alimta and Gemcitabine in Non-Small Cell Lung Cancer
Condition(s): Non-Small Cell Lung Cancer; Stage IIIB or IV Last Updated: February 4, 2009Completed
88
A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non Small Cell Cancer
Condition(s): Non Small Cell Lung Cancer Last Updated: March 13, 2013Active, not recruiting
89
Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer
Condition(s): Non-small Cell Lung Cancer Last Updated: May 5, 2012Recruiting
90
Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).
Condition(s): Lung Cancer Last Updated: February 4, 2013Recruiting
91
A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer
Condition(s): Non Small Cell Lung Cancer Last Updated: December 10, 2010Completed
92
Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)
Condition(s): Non Small Cell Lung Cancer Last Updated: August 18, 2010Completed
93
Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
Condition(s): Squamous Cell Carcinoma of Head and Neck Last Updated: March 2, 2013Recruiting
94
S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Condition(s): Lung Cancer Last Updated: October 3, 2012Terminated
95
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin
Condition(s): Non Small Cell Lung Cancer Last Updated: February 4, 2013Active, not recruiting
96
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
Condition(s): Brain and Central Nervous System Tumors; Lymphoma; Metastatic Cancer Last Updated: June 8, 2012Active, not recruiting
97
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Condition(s): Carcinoma, Non-Small-Cell Lung Last Updated: March 21, 2013Completed
98
Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy
Condition(s): Breast Cancer; Breast Neoplasms Last Updated: May 12, 2009Completed
99
Study of Pemetrexed for Second-Line Pancreas Cancer
Condition(s): Pancreas Cancer Last Updated: March 23, 2011Terminated
100
Pemetrexed Followed by Docetaxel or in Reverse Sequence
Condition(s): Non-small-cell Lung Cancer Last Updated: September 27, 2011Completed
